Genetic Variation of Inflammatory Genes to Ischemic Stroke Risk in a Chinese Han Population.

Pharmacogenomics and Personalized Medicine Pub Date : 2021-08-13 eCollection Date: 2021-01-01 DOI:10.2147/PGPM.S320483
Zhongqiu Zhang, Yanping Mei, Mengqiu Xiong, Fang Lu, Xianghong Zhao, Junrong Zhu, Bangshun He
{"title":"Genetic Variation of Inflammatory Genes to Ischemic Stroke Risk in a Chinese Han Population.","authors":"Zhongqiu Zhang,&nbsp;Yanping Mei,&nbsp;Mengqiu Xiong,&nbsp;Fang Lu,&nbsp;Xianghong Zhao,&nbsp;Junrong Zhu,&nbsp;Bangshun He","doi":"10.2147/PGPM.S320483","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Inflammation proteins play an important role in stroke occurrence. <i>IL1A, IL1B, PTGS2, MMP2</i>, and <i>MMP9</i> were the mediators involved in the immune response, and the association of these genetic variations with ischemic stroke (IS) risk was still unclear.</p><p><strong>Methods: </strong>To investigate the susceptibility of genetic variations of <i>IL1A, IL1B, PTGS2, MMP2</i>, and <i>MMP9</i> to IS risk, we performed a case-control study involving 299 patients and 300 controls in a Chinese population. Thirteen genetic variations of investigated genes of all participants were genotyped using an improved multiplex ligase detection-reaction technique.</p><p><strong>Results: </strong>No SNP in all genes showed an association with overall IS. However, in subgroup analysis, <i>PTGS2</i> rs689466 (dominant model: CT vs TT - OR<sub>adjusted</sub>= 2.51, 95% CI: 1.22-5.16, <i>p</i> = 0.012; co-dominant model: CT/CC vs TT - OR<sub>adjusted</sub>= 2.53, 95% CI: 1.26-5.07, p = 0.009; additive model - OR<sub>adjusted</sub>= 2.26, 95% CI: 1.19-4.28, <i>p</i> = 0.013) and rs5275 (dominant model: GG vs AA - OR<sub>adjusted</sub>= 0.31, 95% CI: 0.12-0.80, <i>p</i> = 0.016; co-dominant model: GA/GG vs AA - OR<sub>adjusted</sub>= 0.45, 95% CI: 0.21-0.95, <i>p</i> = 0.036; additive model - OR<sub>adjusted</sub>= 0.60, 95% CI: 0.39-0.92, <i>p</i> = 0.020) were associated with IS type of small-vessel occlusion.</p><p><strong>Conclusion: </strong>Our study suggested that <i>PTGS2</i> rs689466 C and rs5275 A were potentially associated with IS subtype of small-vessel occlusion. Our result should be confirmed with further large sample sized studies.</p>","PeriodicalId":509088,"journal":{"name":"Pharmacogenomics and Personalized Medicine","volume":" ","pages":"977-986"},"PeriodicalIF":0.0000,"publicationDate":"2021-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/69/fe/pgpm-14-977.PMC8370589.pdf","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacogenomics and Personalized Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/PGPM.S320483","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Background: Inflammation proteins play an important role in stroke occurrence. IL1A, IL1B, PTGS2, MMP2, and MMP9 were the mediators involved in the immune response, and the association of these genetic variations with ischemic stroke (IS) risk was still unclear.

Methods: To investigate the susceptibility of genetic variations of IL1A, IL1B, PTGS2, MMP2, and MMP9 to IS risk, we performed a case-control study involving 299 patients and 300 controls in a Chinese population. Thirteen genetic variations of investigated genes of all participants were genotyped using an improved multiplex ligase detection-reaction technique.

Results: No SNP in all genes showed an association with overall IS. However, in subgroup analysis, PTGS2 rs689466 (dominant model: CT vs TT - ORadjusted= 2.51, 95% CI: 1.22-5.16, p = 0.012; co-dominant model: CT/CC vs TT - ORadjusted= 2.53, 95% CI: 1.26-5.07, p = 0.009; additive model - ORadjusted= 2.26, 95% CI: 1.19-4.28, p = 0.013) and rs5275 (dominant model: GG vs AA - ORadjusted= 0.31, 95% CI: 0.12-0.80, p = 0.016; co-dominant model: GA/GG vs AA - ORadjusted= 0.45, 95% CI: 0.21-0.95, p = 0.036; additive model - ORadjusted= 0.60, 95% CI: 0.39-0.92, p = 0.020) were associated with IS type of small-vessel occlusion.

Conclusion: Our study suggested that PTGS2 rs689466 C and rs5275 A were potentially associated with IS subtype of small-vessel occlusion. Our result should be confirmed with further large sample sized studies.

中国汉族人群炎症基因与缺血性脑卒中风险的遗传变异
背景:炎症蛋白在脑卒中发生中起重要作用。IL1A, IL1B, PTGS2, MMP2和MMP9是参与免疫反应的介质,这些遗传变异与缺血性卒中(IS)风险的关系尚不清楚。方法:为了研究IL1A、IL1B、PTGS2、MMP2和MMP9基因变异对IS风险的易感性,我们在中国人群中进行了一项病例对照研究,涉及299名患者和300名对照。使用改进的多重连接酶检测反应技术对所有参与者的13个基因变异进行基因分型。结果:所有基因中没有SNP显示与总体IS相关。然而,在亚组分析中,PTGS2 rs689466(优势模型:CT vs TT - ORadjusted= 2.51, 95% CI: 1.22-5.16, p = 0.012;共优势模型:CT/CC vs TT - or校正= 2.53,95% CI: 1.26-5.07, p = 0.009;加性模型——ORadjusted= 2.26, 95% CI: 1.19-4.28, p = 0.013)和rs5275(优势模型:GG vs AA——ORadjusted= 0.31, 95% CI: 0.12-0.80, p = 0.016;共优势模型:GA/GG vs AA - or调整= 0.45,95% CI: 0.21-0.95, p = 0.036;加性模型(ORadjusted= 0.60, 95% CI: 0.39-0.92, p = 0.020)与IS型小血管闭塞相关。结论:我们的研究提示PTGS2 rs689466 C和rs5275 A可能与IS亚型小血管闭塞有关。我们的结果需要进一步的大样本研究来证实。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书